Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Drug Discovery Today. Technologies|July 2, 2014
Questions and answers about the Pilot Process for Biomarker Qualification at the FDAFederico M Goodsaid, Felix W FruehDrug Discovery Today. Technologies|July 2, 2014
The Predictive Safety Testing Consortium: A synthesis of the goals, challenges and accomplishments of the Critical PathFederico M Goodsaid, Felix W Frueh, William MattesToxicology|February 19, 2008
Strategic paths for biomarker qualificationFederico M Goodsaid, Felix W Frueh, William MattesAmerican Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 21, 2007
Qualification of biomarkers for drug development in organ transplantationGilbert J Burckart, Shashi Amur, Federico M Goodsaid, et al.Clinical and Translational Science|June 5, 2019
The Labyrinth of Product Development and Regulatory Approvals in Liquid Biopsy DiagnosticsFederico M GoodsaidJournal of Pharmacological and Toxicological Methods|June 3, 2004
Identification and measurement of genomic biomarkers of nephrotoxicityFederico M GoodsaidCurrent Opinion in Drug Discovery & Development|March 5, 2003
Genomic biomarkers of toxicityFederico M GoodsaidPharmacogenomics|July 17, 2009
Back to the future: why randomized controlled trials cannot be the answer to pharmacogenomics and personalized medicineFelix W FruehDrug Discovery Today|October 4, 2011
Considerations for safety pharmacogenetics in clinical practiceFelix W FruehTrends in Molecular Medicine|March 3, 2012
On rat poison and human medicines: personalizing warfarin therapyFelix W FruehPageof 5